GENFIT (GNFT) Stock Chart & Stock Price History $3.68 +0.02 (+0.55%) As of 02:59 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GENFIT Stock Price Performance The GENFIT (GNFT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 15.40%, with a year-to-date return of -0.81%. In the past month, the stock has decreased 11.52%, reflecting recent market activity. As of the latest close, GENFIT traded at $3.69 with a market cap of $184.30 million and volume of 1,680 shares. Five years ago, the stock traded at $5.55, representing a 33.69% decrease over that period. At the time, it had a market cap of $207.32 million and a volume of 23,700 shares. Receive GNFT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for GENFIT and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-3.66%1 Month Performance-11.52%3 Month Performance+9.52%Year-To-Date Performance-0.81%1 Year Performance-15.40%5 Year Performance-33.69% GNFT Stock Chart for Tuesday, July, 8, 2025 GNFT Chart by TradingView GENFIT Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/08/2025$3.69$3.68-0.16%$3.74$3.582,188 shs$184 million07/07/2025$3.82$3.69-3.51%$3.82$3.661,680 shs$184.30 million07/04/2025$3.82$3.82$3.91$3.87330 shs$191 million07/03/2025$3.81$3.82+0.39%$3.91$3.87330 shs$191 million07/02/2025$3.78$3.81+0.66%$3.91$3.79732 shs$190.25 million07/01/2025$3.73$3.78+1.48%$3.85$3.79786 shs$188.99 million06/30/2025$3.61$3.73+3.19%$3.95$3.637,322 shs$186.25 million06/27/2025$3.84$3.61-5.99%$3.88$3.6122,737 shs$180.50 million06/26/2025$3.79$3.84+1.21%$3.89$3.686,888 shs$192 million06/25/2025$3.85$3.79-1.45%$3.99$3.554,421 shs$189.70 million Get the Latest News and Ratings for GNFT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GENFIT and its competitors with MarketBeat's FREE daily newsletter. 06/24/2025$3.81$3.85+1.05%$3.93$3.744,009 shs$192.50 million06/23/2025$3.89$3.81-1.93%$3.91$3.801,863 shs$190.49 million06/20/2025$4.02$3.89-3.26%$3.96$3.932,759 shs$194.25 million06/19/2025$4.02$4.02$4.08$4.04825 shs$200.80 million06/18/2025$4.12$4.02-2.41%$4.08$4.04825 shs$200.80 million06/17/2025$4.13$4.12-0.39%$4.13$4.08396 shs$207.48 million06/16/2025$4.10$4.13+0.76%$4.15$4.15573 shs$206.53 million06/13/2025$4.03$4.10+1.74%$4.18$4.101,507 shs$204.98 million06/12/2025$4.25$4.03-5.18%$4.30$4.039,181 shs$201.48 million06/11/2025$4.23$4.25+0.38%$4.32$4.1712,920 shs$212.48 million06/10/2025$4.25$4.23-0.38%$4.32$4.141,478 shs$211.68 million06/09/2025$4.16$4.25+2.19%$4.29$4.051,652 shs$212.48 million Related Companies Replimune Group Stock Price Chart Vir Biotechnology Stock Price Chart Sionna Therapeutics Stock Price Chart Gyre Therapeutics Stock Price Chart Phathom Pharmaceuticals Stock Price Chart AnaptysBio Stock Price Chart Immatics Stock Price Chart Trevi Therapeutics Stock Price Chart Nuvation Bio Stock Price Chart Day One Biopharmaceuticals Stock Price Chart Receive GNFT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for GENFIT and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GNFT) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GENFIT S.A. Unsponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share GENFIT With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.